Published in J Urol on February 01, 2005
Patient perceptions of physical and emotional discomfort related to urodynamic testing: a questionnaire-based study in men and women with and without neurologic conditions. Urology (2015) 0.77
Noninvasive Evaluation of Bladder Wall Mechanical Properties as a Function of Filling Volume: Potential Application in Bladder Compliance Assessment. PLoS One (2016) 0.75
Prospective evaluation of anxiety, pain, and embarrassment associated with cystoscopy and urodynamic testing in clinical practice. Can Urol Assoc J (2017) 0.75
Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol (2003) 18.01
Autonomic nerve development contributes to prostate cancer progression. Science (2013) 6.11
Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst (2005) 5.29
Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry (2007) 3.92
Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (2008) 3.73
T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis (2011) 3.38
Cognitive processes related to gait velocity: results from the Einstein Aging Study. Neuropsychology (2006) 3.34
Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. J Urol (2010) 2.68
Artificial urinary sphincter revision: the role of ultrasound. Urology (2013) 2.62
Multicenter, randomized, controlled trial of virtual-reality simulator training in acquisition of competency in colonoscopy. Gastrointest Endosc (2006) 2.33
CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials. JACC Cardiovasc Imaging (2012) 2.27
Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res (2008) 2.24
The relationship between specific cognitive functions and falls in aging. Neuropsychology (2007) 2.17
Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women. J Infect Dis (2012) 2.16
A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer. Cancer Epidemiol Biomarkers Prev (2008) 2.01
Contemporary management of postprostatectomy incontinence. Eur Urol (2011) 2.01
Walking while talking: effect of task prioritization in the elderly. Arch Phys Med Rehabil (2007) 2.01
Gait dysfunction in mild cognitive impairment syndromes. J Am Geriatr Soc (2008) 2.00
Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology (2002) 1.90
Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. JAMA (2005) 1.86
Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Infect Dis (2010) 1.85
An artificial somatic-central nervous system-autonomic reflex pathway for controllable micturition after spinal cord injury: preliminary results in 15 patients. J Urol (2003) 1.73
Managing the urethra at transvaginal pelvic organ prolapse repair: a urodynamic approach. J Urol (2008) 1.67
T cell activation predicts carotid artery stiffness among HIV-infected women. Atherosclerosis (2011) 1.64
Outcomes after an excisional procedure for cervical intraepithelial neoplasia in HIV-infected women. Gynecol Oncol (2010) 1.64
A prospective investigation of coffee drinking and endometrial cancer incidence. Int J Cancer (2011) 1.56
Urodynamic studies in adults: AUA/SUFU guideline. J Urol (2012) 1.51
Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction. Rev Urol (2005) 1.49
Long-term mortality after preeclampsia. Epidemiology (2005) 1.44
Treatment-related changes in serum lipids and inflammation: clinical relevance remains unclear. Analyses from the Women's Interagency HIV study. AIDS (2013) 1.43
Epithelial ovarian carcinoma and fertility of parents. Epidemiology (2002) 1.38
Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment. J Acquir Immune Defic Syndr (2012) 1.37
Proton MR spectroscopy of tumefactive demyelinating lesions. AJNR Am J Neuroradiol (2002) 1.36
Adipokines linking obesity with colorectal cancer risk in postmenopausal women. Cancer Res (2012) 1.35
Colorectal neoplasms: prospective comparison of thin-section low-dose multi-detector row CT colonography and conventional colonoscopy for detection. Radiology (2002) 1.32
Artificial urinary sphincter versus male sling for post-prostatectomy incontinence--what do patients choose? J Urol (2009) 1.30
American Urological Association Symptom Index for lower urinary tract symptoms in women: correlation with degree of bother and impact on quality of life. Urology (2003) 1.30
Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology (2010) 1.28
Conventional and robust quantitative gait norms in community-dwelling older adults. J Am Geriatr Soc (2010) 1.26
Self-reported difficulty in climbing up or down stairs in nondisabled elderly. Arch Phys Med Rehabil (2008) 1.24
ARC (apoptosis repressor with caspase recruitment domain) is a novel marker of human colon cancer. Cell Cycle (2008) 1.21
Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol Urodyn (2013) 1.17
Reproductive history and risk of colorectal cancer in postmenopausal women. J Natl Cancer Inst (2011) 1.16
A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers. Cancer Epidemiol Biomarkers Prev (2011) 1.15
Comparison of diagnostic criteria for female bladder outlet obstruction. J Urol (2006) 1.14
Skin cancer after X-ray treatment for scalp ringworm. Radiat Res (2002) 1.14
The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women. J Infect Dis (2011) 1.13
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. Blood (2013) 1.13
Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study. Mayo Clin Proc (2008) 1.11
Review article: Mid-urethral synthetic slings for female stress urinary incontinence. BJU Int (2010) 1.10
Continence following radical retropubic prostatectomy using self-reporting instruments. J Urol (2004) 1.09
Impact of fusion of indium-111 capromab pendetide volume data sets with those from MRI or CT in patients with recurrent prostate cancer. AJR Am J Roentgenol (2004) 1.08
Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection. JAMA (2012) 1.06
A prospective evaluation of C-reactive protein levels and colorectal adenoma development. Cancer Epidemiol Biomarkers Prev (2011) 1.06
Association of subclinical atherosclerosis with lipid levels amongst antiretroviral-treated and untreated HIV-infected women in the Women's Interagency HIV study. Atherosclerosis (2012) 1.01
Female urethral reconstruction. Urol Clin North Am (2011) 1.01
Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women. J Gen Virol (2005) 1.00
Female stress urinary incontinence: how do patient and physician perspectives correlate in assessment of outcomes? Curr Opin Urol (2006) 0.99
Effect of 5 y of calcium plus vitamin D supplementation on change in circulating lipids: results from the Women's Health Initiative. Am J Clin Nutr (2010) 0.98
Cancer after pre-eclampsia: follow up of the Jerusalem perinatal study cohort. BMJ (2004) 0.98
The analysis of multivariate interval-censored survival data. Stat Med (2002) 0.96
Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer. Breast Cancer Res (2012) 0.96
Additive hazard regression models: an application to the natural history of human papillomavirus. Comput Math Methods Med (2013) 0.95
The male perineal sling: assessment and prediction of outcome. J Urol (2007) 0.95
Surgical management of Skene's gland abscess/infection: a contemporary series. Int Urogynecol J (2011) 0.95
Effect of tension-free vaginal tape and TVT-obturator on lower urinary tract symptoms other than stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.94
County level socioeconomic position, work organization and depression disorder: a repeated measures cross-classified multilevel analysis of low-income nursing home workers. Health Place (2005) 0.94
Sample size requirements to detect an intervention by time interaction in longitudinal cluster randomized clinical trials with random slopes. Comput Stat Data Anal (2013) 0.93
Transient versus persistent fear of falling in community-dwelling older adults: incidence and risk factors. J Am Geriatr Soc (2011) 0.92
Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas. J Natl Cancer Inst (2009) 0.92
Genital tract HIV RNA levels and their associations with human papillomavirus infection and risk of cervical precancer. J Acquir Immune Defic Syndr (2014) 0.91
Human leukocyte antigen genotype and risk of HIV disease progression before and after initiation of antiretroviral therapy. J Virol (2011) 0.91
A urodynamics protocol to optimally assess men with post-prostatectomy incontinence. Neurourol Urodyn (2005) 0.90
Iron homeostasis and distal colorectal adenoma risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Prev Res (Phila) (2011) 0.90
Primary bladder neck obstruction in men and women. Rev Urol (2005) 0.90
Botulinum toxin for the treatment of idiopathic and neurogenic overactive bladder: state of the art. Rev Urol (2006) 0.90
Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3). Growth Horm IGF Res (2006) 0.89
Urinary incontinence. Prim Care (2010) 0.88
Insulin-like growth factor axis and oncogenic human papillomavirus natural history. Cancer Epidemiol Biomarkers Prev (2008) 0.88
Predisability and gait patterns in older adults. Gait Posture (2010) 0.88
Pubovaginal sling and pelvic prolapse repair in women with occult stress urinary incontinence: effect on postoperative emptying and voiding symptoms. Urology (2002) 0.87
Treatment of post-prostatectomy incontinence with male slings in patients with impaired detrusor contractility on urodynamics and/or who perform Valsalva voiding. J Urol (2011) 0.87
Work organization, area labor-market characteristics, and depression among U.S. nursing home workers: a cross-classified multilevel analysis. Int J Occup Environ Health (2005) 0.87
Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder. Int Urogynecol J (2014) 0.87
Comparison of BIOMED-2 versus laboratory-developed polymerase chain reaction assays for detecting T-cell receptor-gamma gene rearrangements. J Mol Diagn (2010) 0.87
Estimation and inference on correlations between biomarkers with repeated measures and left-censoring due to minimum detection levels. Stat Med (2012) 0.86
Germinal center and activated b-cell profiles separate Burkitt lymphoma and diffuse large B-cell lymphoma in AIDS and non-AIDS cases. Am J Clin Pathol (2005) 0.86
Approaches for calculating power for case-cohort studies. Biometrics (2006) 0.85
PAH-DNA adducts in a Chinese population: relationship to PAH exposure, smoking and polymorphisms of metabolic and DNA repair genes. Biomarkers (2008) 0.85
Association of cutaneous anergy with human papillomavirus and cervical neoplasia in HIV-seropositive and seronegative women. AIDS (2007) 0.85
Sample size requirement to detect an intervention effect at the end of follow-up in a longitudinal cluster randomized trial. Stat Med (2010) 0.85
Clinical impact of overactive bladder. Rev Urol (2002) 0.85
Midurethral slings for all stress incontinence: a urology perspective. Urol Clin North Am (2012) 0.85
Effect of P sources on growth, P accumulation and activities of phytase and acid phosphatases in two cultivars of annual ryegrass (Lolium multiflorum L.). Plant Physiol Biochem (2007) 0.85
Management of recurrent urinary tract infections in healthy adult women. Rev Urol (2013) 0.84
Repeat urethrolysis after failed urethrolysis for iatrogenic obstruction. J Urol (2003) 0.84
Defining efficacy in the treatment of overactive bladder syndrome. Rev Urol (2009) 0.84
Degree of bother caused by nocturia in women. Neurourol Urodyn (2004) 0.83